https://scholars.lib.ntu.edu.tw/handle/123456789/565634
標題: | Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia | 作者: | Ran Z. Wu K. Matsuoka K. Jeen Y.T. SHU-CHEN WEI Ahuja V. Chen M. Hu P.-J. Andoh A. Kim H.J. Yang S.-K. Watanabe M. Ng S.C. Hibi T. Hilmi I.N. Suzuki Y. Han D.S. Leung W.K. Sollano J. Ooi C.J. Qian J. |
關鍵字: | biologics; chronic ulcerative colitis; Clostridium difficile; Crohn's disease; cytomegalovirus; inflammatory bowel disease; intestinal tuberculosis | 公開日期: | 2021 | 出版社: | Blackwell Publishing | 卷: | 36 | 期: | 3 | 起(迄)頁: | 637-645 | 來源出版物: | Journal of Gastroenterology and Hepatology (Australia) | 摘要: | Inflammatory bowel disease (IBD) has increased in incidence and prevalence in Asian countries since the end of the 20th century. Moreover, differences in the cause, phenotypes, and natural history of IBD between the East and West have been recognized. Therefore, the Asian Organization for Crohn's and Colitis and the Asia Pacific Association of Gastroenterology have established recommendations on medical management of IBD in Asia. Initially, the committee members drafted 40 recommendations, which were then assessed according to Grading of Recommendations Assessment, Development and Evaluation. Eight statements were rejected as this indicated that consensus had not been reached. The recommendations encompass pretreatment evaluation; medical management of active IBD; medical management of IBD in remission; management of IBD during the periconception period and pregnancy; surveillance strategies for colitis-associated cancer; monitoring side effects of thiopurines and methotrexate; and infections in IBD. ? 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088692907&doi=10.1111%2fjgh.15185&partnerID=40&md5=5a589b98020f7c2937648201ff890bd9 https://scholars.lib.ntu.edu.tw/handle/123456789/565634 |
ISSN: | 0815-9319 | DOI: | 10.1111/jgh.15185 | SDG/關鍵字: | biological product; immunosuppressive agent; mercaptopurine; mesalazine; methotrexate; salazosulfapyridine; steroid; tuberculostatic agent; aminosalicylic acid; azathioprine; corticosteroid; immunosuppressive agent; adverse drug reaction; anus disease; Asia; chemoprophylaxis; colitis; Crohn disease; differential diagnosis; disease activity; disease surveillance; gastroenterology; health care organization; human; infection; inflammatory bowel disease; intestinal tuberculosis; latent tuberculosis; medical practice; opportunistic infection; patient monitoring; pregnancy; priority journal; remission; Review; screening; ulcerative colitis; Crohn disease; female; gastroenterology; gastrointestinal tuberculosis; male; medical society; organization and management; Pacific islands; physiologic monitoring; practice guideline; ulcerative colitis; Adrenal Cortex Hormones; Aminosalicylic Acid; Asia; Azathioprine; Colitis, Ulcerative; Crohn Disease; Diagnosis, Differential; Female; Gastroenterology; Humans; Immunosuppressive Agents; Male; Methotrexate; Monitoring, Physiologic; Pacific Islands; Practice Guidelines as Topic; Pregnancy; Remission Induction; Societies, Medical; Tuberculosis, Gastrointestinal |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。